FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND reported 1 transaction at OPUS GENETICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/6/2025ACC: 0001578563-25-000238
→
DirectorOther
Since Oct 2024
+6.92M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
6.93M acquired · 6.93K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.93M
Price / share
—
Trade value
—
% of position
270.1%
5/5/2025
2.56M→9.49M
Total
Net shares
+6.93M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/5/2025 | C · Conversion | +6.93M | — | — | 270.1% | 2.56M | 9.49M |
| Total | +6.93M | $0.00 | ||||||
Derivative Transactions1
Series A Non-Voting Convertible Preferred Stock
Direct
Converts to
Common Stock
6.93M shares
Shares
−6.93K
Strike price
Held after
0.00
Exercisable
—
5/5/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Non-Voting Convertible Preferred Stock Direct | Common Stock6.93M shares | 5/5/2025 | C · Conversion | −6.93K | — | 0.00 |